Medically reviewed by Archana Sharma, DO Uterine cancer is staged using the FIGO and TNM systems based on tumor size, lymph ...

The most common type of gynecologic cancer in the U.S. has been on the rise in recent years — and there’s no standard screening for it. Uterine cancer will affect about 66,200 women in 2023 in the U.S ...

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...

Recent studies highlight the effectiveness of lenvatinib and pembrolizumab in improving overall survival for patients with ...

A recent study has found that Black women may be at a higher risk for uterine cancer because of harmful chemicals in some hair straightening products. These chemicals affect your body’s hormones.

University of Iowa doctoral student Katie Colling is making progress in identifying hormones that are effective at combating ...

An international team including the National Cancer Center Japan analyzed trends in early-onset cancers diagnosed in 44 ...

Real-world data reinforces the efficacy and tolerability of lenvatinib and pembrolizumab for treating recurring endometrial cancer.

Research led by a University of Iowa student is opening new doors to potential uterine cancer treatments that could allow ...

Previous studies have linked chemicals in some hair products to breast cancer. New research has found hair straightening chemicals may increase risk of uterine cancer. Risk was doubled for those ...